SEARCH

SEARCH BY CITATION

References

  • 1
    Thompson AW. FK-506: Profile of an important new immunosuppressant. Transplant Rev 1990; 4:113.
  • 2
    Benoit JN, Korthuis RJ, Granger DN, Battarbee HD. Splanchnic hemodynamics in acute and chronic portal hypertension. In: BomzonA, BlendisLM, eds. Cardiovascular complications of liver disease. Boca Raton: CRC, 1990;179206.
  • 3
    Mange KC, Cizman B, Joffe M, Feldman HI. Arterial hypertension and renal allograft survival. JAMA 2000; 283:633638.MEDLINE
  • 4
    Peschke B, Scheuermann EH, Geiger H, Bolscher S, Kachel HG, Lenz T. Hypertension is associated with hyperlipidemia, coronary artery disease, and chronic graft failure in kidney transplant recipients. Clin Nephrol 1999; 51:290295.MEDLINE
  • 5
    Schwartz L, Augustine J, Raymer J, Canzanello VJ, Taler SJ, Textor SC. Nurse management of posttransplant hypertension in liver transplant patients. J Transplant Coord 1996; 6:139144.
  • 6
    Canzanello VJ, Schwartz L, Taler SJ, Textor SC, Wiesner RH, Porayko MK, et al. Evolution of cardiovascular risk after liver transplantation: A comparison of cyclosporine A and tacrolimus (FK506). Liver Transpl Surg 1997; 3:19.MEDLINE
  • 7
    Taler SJ, Textor SC, Canzanello VJ, Schwartz L, Porayko M, Wiesner RH, et al. Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine. Transplantation 1996; 62:15881592.MEDLINE
  • 8
    Canzanello VJ, Textor SC, Taler SJ, Schwartz L, Porayko M, Wiesner RH, et al. Late hypertension after liver transplantation: A comparison of cyclosporine and tacrolimus (FK506). Liver Transpl Surg 1998; 4:328334.MEDLINE
  • 9
    Textor SC, Wiesner R, Wilson DJ, Porayko M, Romero JC, Burnett JC, et al. Systemic and renal hemodynamic differences between FK506 and cyclosporine A in liver transplant recipients. Transplantation 1993; 55:13321339.MEDLINE
  • 10
    Copley JB, Staffeld C, Lindberg J, Hansen A, Bailey C, Anand R, et al. Cyclosporine to tacrolimus: Effect on hypertension and lipid profiles in renal allografts. Transplant Proc 1998; 30:12541256.MEDLINE
  • 11
    Ellis D, Shaprio R, Jordan ML, Cantlebury VP, Gilboa N, Hopp L, et al. Comparison of FK506 and cyclosporine regimens in pediatric renal transplantation. Pediatr Nephrol 1994; 8:193200.MEDLINE
  • 12
    Taler SJ, Textor SC, Canzanello VJ, Schwartz L. Cyclosporin-induced hypertension: Incidence, pathogenesis and management. Drug Safety 1999; 20:437449.MEDLINE
  • 13
    Ventura HO, Mehra MR, Stapleton D, Smart FW. Cyclosporine-induced hypertension in cardiac transplantation. Med Clin North Am 1997; 81:13471357.MEDLINE
  • 14
    Luke RG. Essential hypertension: A renal disease? A review and update of the evidence. Hypertension 1993; 21:380390.MEDLINE
  • 15
    Textor SC. De-novo hypertension after liver transplantation. Hypertension 1993; 22:257267.MEDLINE
  • 16
    Curtis JJ, Luke RG, Jones P, Diethelm AG. Hypertension in cyclosporine-treated renal transplant recipients is sodium-dependent. Am J Med 1988; 85:134138.MEDLINE
  • 17
    Canzanello VJ, Textor SC, Taler SJ, Wilson DJ, Schwartz L, Wiesner RH, et al. Renal sodium handling with cyclosporine A and FK506 after orthotopic liver transplantation. J Am Soc Nephrol 1995; 5:19101917.MEDLINE
  • 18
    Ciresi DL, Lloyd MA, Sandberg SM, Heublein DM, Edwards BS. The sodium retaining effects of cyclosporine. Kidney Int 1992; 41:15991605.MEDLINE
  • 19
    Guyton AC. Dominant role of the kidneys in long-term regulation of arterial pressure and hypertension: The integrated system for pressure control. In: GuytonAC, ed. Textbook of Medical Physiology. Philadelphia: Saunders, 1991:205220.
  • 20
    Hansen JM, Fogh-Andersen N, Christensen NJ, Strandgaard S. Cyclosporine-induced hypertension and decline in renal function in healthy volunteers. J Hypertens 1997; 15:319326.MEDLINE
  • 21
    Sturrock NDC, Lang CC, Struthers AD. Cyclosporin-induced hypertension precedes renal dysfunction and sodium retention in man. J Hypertens 1993; 11:12091216.MEDLINE
  • 22
    Scherrer U, Vissing SF, Morgan BJ, Rollins JA, Tindall RS, Ring S, et al. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990; 323:693699.MEDLINE
  • 23
    Sander M, Victor RG. Hypertension after cardiac transplantation: Pathophysiology and management. Curr Opin Nephrol Hypertens 1995; 4:443451.MEDLINE
  • 24
    Floras JS, Legault L, Morali GA, Hara K, Blendis LM. Increased sympathetic outflow in cirrhosis and ascites: Direct evidence from intraneural recordings. Ann Intern Med 1991; 114:373380.MEDLINE
  • 25
    Kaye D, Thompson J, Jennings G, Esler M. Cyclosporine therapy after cardiac transplantation causes hypertension and renal vasoconstriction without sympathetic activation. Circulation 1993; 88:11011109.MEDLINE
  • 26
    Rundqvist B, Casale R, Bergmann-Sverrisdottir Y, Friberg P, Mortara A. Rapid fall in sympathetic nerve hyperactivity in patients with heart failure after cardiac transplantation. J Card Fail 1997; 3:2126.MEDLINE
  • 27
    Bantle JP, Paller MS, Boudreau RJ, Olivari MT, Ferris TF. Long-term effects of cyclosporine on renal function in organ transplant recipients. J Lab Clin Med 1990; 115:233240.MEDLINE
  • 28
    Lee DB. Cyclosporine and the renin-angiotensin axis. Kidney Int 1997; 52:248260.MEDLINE
  • 29
    Rutan GH, Shapiro AP, Thompson ME, Nigalye RL, McDonald RH, Johnsen AM, et al. Hypertension, creatinine, and plasma renin activity in heart transplant recipients. J Hum Hypertens 1990; 4:659664.MEDLINE
  • 30
    Textor SC, Canzanello VJ, Taler SJ, Romero JC, Porayko M, Wiesner RH, et al. Activation of the renin-angiotensin system and sustained endothelin release two years after liver transplantation [abstract]. Circulation 1994; 90:I73.
  • 31
    Brozena SC, Johnson MR, Ventura H, Hobbs R, Miller L, Olivari MT, et al. Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after heart transplantation. J Am Coll Cardiol 1996; 27:17071712.MEDLINE
  • 32
    Elliot WJ, Murphy MB, Karp R. Long-term preservation of renal function in hypertensive heart transplant recipients treated with enalapril and a diuretic. J Heart Lung Transplant 1991; 10:373379.MEDLINE
  • 33
    Hausberg M, Barenbrock M, Hohage H, Muller S, Heidenreich S, Rahn KH. ACE inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients. Hypertension 1999; 33:862868.MEDLINE
  • 34
    Textor SC, Wilson DJ, Lerman A, Romero JC, Burnett JC, Wiesner R, et al. Renal hemodynamics, urinary eicosanoids, and endothelin after liver transplantation. Transplantation 1992; 54:7480.MEDLINE
  • 35
    Clark WF, Moist LM. Management of chronic renal insufficiency in lupus nephritis: Role of proteinuria, hypertension and dyslipidemia in the progression of renal disease [abstract]. Lupus 1998; 7:649653.MEDLINE
  • 36
    Textor SC, Taler SJ, Burnett JC, Schwartz L, Schwartz D, Trushina E, et al. Reduced urinary second messenger (cGMP) and reduced endothelin release from l-arginine despite normal plasma nitric oxide levels in cyclosporine hypertension [abstract]. J Am Soc Nephrol 1998; 9:316A.
  • 37
    Gallego MJ, Garcia-Villalon AL, Lopez-Farre AJ, Garcia JL, Garron MP, Casado S, et al. Mechanisms of the endothelial toxicity of cyclosporin A. Role of nitric oxide, cGMP and CA2+. Circ Res 1994; 74:477484.MEDLINE
  • 38
    Akita K, Dusting GJ, Hickey H. Suppression of nitric oxide production by cyclosporin A and FK506A in rat vascular smooth muscle cells. Clin Exp Pharmacol Physiol 1994; 21:231233.MEDLINE
  • 39
    Conde M, Andrade J, Bedoya FJ, Santa Maria C, Sobrino F. Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages. Evidence of a direct effect on nitric oxide synthase activity. Immunology 1995; 84:476481.MEDLINE
  • 40
    Oriji GK, Keiser HR. Role of nitric oxide in cyclosporine A-induced hypertension. Hypertension 1998; 32:849855.MEDLINE
  • 41
    Vaziri ND, Ni Z, Zhang YP, Ruzics EP, Pejman M, Ding Y. Depressed renal and vascular nitric oxide synthase expression in cyclosporine-induced hypertension. Kidney Int 1998; 54:482491.MEDLINE
  • 42
    Bracht C, Yan XW, LaRocca HP, Sutsch G, Kiowski W. Cyclosporine A and control of vascular tone in the human forearm: Influence of post-transplant hypertension. J Hypertens 1999; 17:357363.MEDLINE
  • 43
    Bokemeyer D, Friedrichs U, Baecker A, Drechsler S, Kramer HJ, Meyer-Lehnert H. Atrial natriuretic peptide inhibits cyclosporine-A induced endothelin production and calcium accumulation in rat vascular smooth muscle cells. Clin Sci 1994; 87:383387.MEDLINE
  • 44
    Bunchman TE, Brookshire CA. Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells. J Clin Invest 1991; 88:310314.MEDLINE
  • 45
    Deray G, Carayon A, Le Hoang P. Increased endothelin level after cyclosporine therapy. Ann Intern Med 1991; 114:809809.MEDLINE
  • 46
    Perico N, Ruggenenti P, Gaspari F, Mosconi L, Benigni A, Amuchastegui CS, et al. Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation. Transplantation 1992; 54:5660.MEDLINE
  • 47
    Textor SC, Burnett JC, Romero JC, Canzanello VJ, Taler SJ, Wiesner RH, et al. Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation. Kidney Int 1995; 47:14261433.MEDLINE
  • 48
    Wolf G, Thaiss F, Stahl RA. Cyclosporine stimulates expression of transforming growth factor-beta in renal cells: Possible mechanism of cyclosporine's antiproliferative effects. Transplantation 1995; 60:237241.MEDLINE
  • 49
    Bartholomeusz B, Hardy KJ, Nelson AS, Phillips PA. Bosentan ameliorates cyclosporin A-induced hypertension in rats and primates. Hypertension 1996; 27:13411345.MEDLINE
  • 50
    Reece DE, Frei Lahr DA, Shepherd JD, Dorovini Zis K, Gascoyne RD, Graeb DA, et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant 1991; 8:393401.MEDLINE
  • 51
    Textor SC, Forman SJ, Bravo EL, Carlson J. De-novo accelerated hypertension during sequential cyclosporine and prednisone therapy in normotensive bone marrow transplant recipients. Transplant Proc 1988; 20(suppl 3):480486.MEDLINE
  • 52
    Hricik DE, Mayes JT, Schulak JA. Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia. Am J Kidney Dis 1991; 18:353358.MEDLINE
  • 53
    Taylor DO, Barr ML, Radovancevic B, Renlund DG, Mentzer RM, Smart FW. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: Decreased hyperlipidemia and hypertension with tacrolimus. J Heart Lung Transplant 1999; 18:336345.MEDLINE
  • 54
    Textor SC. Renal parenchymal disease and hypertension. In: WilcoxCS, ed. Hypertension and the kidney. Philadelphia: Current Medicine, 1999;2.12.15.
  • 55
    Taler SJ, Textor SC, Canzanello VJ, Wilson DJ, Wiesner RH, Krom RA. Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapy. Am J Hypertens 1995; 8:598605.MEDLINE
  • 56
    Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. Ambulatory blood pressure: An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24:793801.MEDLINE
  • 57
    Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese V. Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 1994; 7:2329.MEDLINE
  • 58
    Shimada K, Kawamoto A, Matsubayashi K, Nishinaga M, Kimura S, Ozawa T. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens 1992; 10:875878.MEDLINE
  • 59
    van de Borne P, Gelin M, Van de Stadt J, Degaute JP. Circadian rhythms of blood pressure after liver transplantation. Hypertension 1993; 21:398405.MEDLINE
  • 60
    van de Borne P, Leeman M, Primo G, Degaute JP. Reappearance of a normal circadian rhythm of blood pressure after cardiac transplantation. Am J Cardiol 1992; 69:794801.MEDLINE
  • 61
    Textor SC, Schwartz L, Canzanello VJ, Wiesner R, Taler SJ, Porayko M, et al. Resolution of post-transplant hypertension after liver transplantation despite impaired glomerular filtration. J Am Soc Nephrol 1994; 5:12231230.MEDLINE
  • 62
    Gerhard M, Roddy SJ, Creager MA. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension 1996; 27:849853.MEDLINE
  • 63
    Taler SJ, Textor SC, Canzanello VJ, Schwartz L, Porayko M, Wiesner R. Renal function predicts hypertension severity and circadian BP patterns five years after liver transplantation [abstract]. J Am Soc Nephrol 1998; 9:717A.
  • 64
    Textor SC, Schwartz L, Wilson DJ, Wiesner R, Romero JC, Augustine J, et al. Systemic and renal effects of nifedipine in cyclosporine-associated hypertension. Hypertension 1994;23(suppl I):I-220I-224.
  • 65
    Taler SJ, Textor SC, Canzanello VJ, Schwartz L, Porayko MK, Wiesner RH, et al. Hypertension after liver transplantation: A predictive role for pretreatment hemodynamics and effects of isradipine on the systemic and renal circulations. Am J Hypertens 2000; 13:231239.MEDLINE
  • 66
    Mourad G, Ribstein J, Mimran A. Converting-enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplants. Kidney Int 1993; 43:419425.MEDLINE
  • 67
    Elzinga LW, Rosen S, Bennett WM. Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporine nephropathy: Role of sodium intake. J Am Soc Nephrol 1993; 4:214221.MEDLINE
  • 68
    Krom RAF, Wiesner RH, Rettke SR, Ludwig J, Southorn PA, Hermans PE, et al. The first 100 liver transplantations at the Mayo Clinic. Mayo Clin Proc 1989; 64:8494.MEDLINE
  • 69
    Textor SC, Canzanello VJ, Taler SJ, Wilson DJ, Schwartz L, Augustine J, et al. Cyclosporine-induced hypertension after transplantation. Mayo Clinic Proc 1994; 69:11821193.